Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Kaj Blennow

Professor/ chief physician

Kaj Blennow
Professor/ chief physician
kaj.blennow@clinchem.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Laborativ neurovetenskap , Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Kaj Blennow

Latest publications

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
S. J. van der Lee, O. J. Conway, I. Jansen, M. M. Carrasquillo, L. Kleineidam et al.
Acta Neuropathologica, Journal article 2019
Journal article

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
S. Fossati, J. Ramos Cejudo, L. Debure, E. Pirraglia, J. Y. Sone et al.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Journal article 2019
Journal article

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression
S. De, D. R. Whiten, F. S. Ruggeri, C. Hughes, M. Rodrigues et al.
Acta Neuropathologica Communications, Journal article 2019
Journal article

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
L. Vermunt, S. A. M. Sikkes, A. van den Hout, R. Handels, I. Bos et al.
Alzheimers & Dementia, Journal article 2019
Journal article

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
S. L. Allison, R. L. Koscik, R. P. Cary, E. M. Jonaitis, H. A. Rowley et al.
NeuroImage: Clinical, Journal article 2019
Journal article

Showing 1 - 10 of 1046

2019

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
S. J. van der Lee, O. J. Conway, I. Jansen, M. M. Carrasquillo, L. Kleineidam et al.
Acta Neuropathologica, Journal article 2019
Journal article

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
S. Fossati, J. Ramos Cejudo, L. Debure, E. Pirraglia, J. Y. Sone et al.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Journal article 2019
Journal article

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression
S. De, D. R. Whiten, F. S. Ruggeri, C. Hughes, M. Rodrigues et al.
Acta Neuropathologica Communications, Journal article 2019
Journal article

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
L. Vermunt, S. A. M. Sikkes, A. van den Hout, R. Handels, I. Bos et al.
Alzheimers & Dementia, Journal article 2019
Journal article

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
S. L. Allison, R. L. Koscik, R. P. Cary, E. M. Jonaitis, H. A. Rowley et al.
NeuroImage: Clinical, Journal article 2019
Journal article

Showing 1 - 10 of 1046

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?